Fresenius SE is an international healthcare group providing products and services for dialysis, hospitals and the medical care of patients at home. In addition, Fresenius focuses on hospital operation, as well as on engineering and services for hospitals and other healthcare facilities.
The group comprises the business segments Fresenius Medical Care (FMC), Fresenius Kabi, Fresenius Helios and Fresenius Vamed, all of which are legally-independent entities managed by the operating parent company Fresenius SE. This group structure has been in place since 1st January 2008. Prior to this date, Fresenius Helios and Fresenius Vamed formed a single business segment called Fresenius ProServe.
The Fresenius Medical Device Company Report provides a full review of the company's medical device activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures and litigation. Sections are also included on products, corporate strategy and R&D.
Whatever your interest or involvement, evaluating the performance, success, failures and developments of medical companies is critical. Espicom’s Medical Device Company Reports have been regularly published for over 20 years, and these critically acclaimed and respected management reports provide a complete review of leading players in the field.
Evaluate competitive threats Maximise product and market opportunities Identify collaborators and strategic partners Understand the operating market environment Benchmark your performance against competitors Coverage Overview
Key contact information Introduction to Fresenius and its current activities Summary of its financial performance Key recent events in an “at a glance” format Strategic Focus
The company’s aims and its areas of focus Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available) Table providing in-depth five-year financial analysis Employee data, including breakdown by company division and geographic location Product Overview
Core product areas, key brands, product approvals and launches Identifies the company’s major competitors Research and Development
How much has been invested in R&D? Where is the research based? What alliances and agreements does Fresenius have and with whom? Manufacturing and Distribution
Identifying the company’s manufacturing locations Sales and marketing facilities Agreements
With whom has Fresenius reached agreements and what do they involve? Key contracts awarded Mergers and Acquisitions
Key Corporate Events
The report was produced as part of Medical Device Companies Analysis (MDCA).
Table Of Contents
Fresenius Medical Device Company Intelligence Report Table of Contents
OVERVIEW 2 STRATEGIC FOCUS 3 Fresenius Medical Care 3 Espicom View 4 FINANCIAL REVIEW 6 2012 Financial Results 6 Fresenius Medical Care (FMC) 7 Fresenius Kabi 10 Fresenius Helios 11 Fresenius Vamed 11 Five-Year Financial Data 12 Outlook 13 Employees 14 PRODUCTS 15 FMC 15 Dialysis Market 15 Dialysis Products 17 HD Products 17 Acute Therapy 20 PD Products 21 CAPD Therapy 21 APD Therapy 21 Other PD Products 22 Therapeutic Apheresis 22 Renal Pharmaceuticals 22 Fresenius Kabi 24 Infusion Therapy 24 Parenteral Nutrition 24 Enteral Nutrition 24 Infusion Technology 24 Transfusion Technology 24 Ambulatory Care25 RESEARCH AND DEVELOPMENT 26 RandD Expenditure 26 RandD Employees 27 RandD Facilities and Activities 27 FMC 27 RandD Activities 27 Artificial Kidney 27 Future RandD 28 RandD Employees and Facilities 29 Fresenius Kabi 29 MANUFACTURING AND DISTRIBUTION 30 FMC 30 Fresenius Kabi 31 AGREEMENTS 33 Interface Biologics 33 Abu Dhabi Health Services 33 Public Health Authorities in Murcia, Spain 33 Galenica, Luitpold Pharmaceuticals and Vifor International 34 MERGERS AND ACQUISITIONS 35 Fenwal 35 H C Hospital Consulting 35 Damp Group 35 Fresenius Medical Care 35 Liberty Dialysis Holdings 36 JOINT VENTURES 37 Vifor-Fresenius Medical Care Renal Pharma Ltd 37 Frebor 37 Fresenius Kawasumi 37 Renal Research Institute 37 Sino-Swed Pharmaceutical Corp Ltd 38 DIVESTITURES 39 Calea France 39 Fresenius Biotech 39 Sale of Dialysis Clinics to DSI Renal 39 LITIGATION 40 Diasylate Concentrate Products 40 KEY CORPORATE EVENTS 41
List of Tables Recent Key Events 2 FMC - Goal 13 Targets 4 Fresenius SE - Annual Financial Results, 2008-2012 6 Fresenius SE - Annual Sales by Geographic Area, 2008-2012 7 FMC - Annual Financial Results, 2008-2012 7 FMC - Annual Revenues by Geographic Area, 2008-2012 9 Fresenius Kabi - Annual Financial Results, 2008-2012 10 Fresenius Kabi - Annual Revenues by Geographic Area, 2008-2012 10 Fresenius Helios - Annual Financial Results, 2008-2012 11 Fresenius Vamed - Annual Financial Results, 2008-2012 11 Fresenius - Five-Year Financial Data 12 Fresenius SE Employees, 2008-2012 14 2012 Company Market Positions by Dialysis Product Groups 16 Fresenius Kabi - Medical Device Product Summary 25 Fresenius Group - RandD Expenditure, 2008-2012 26 Fresenius Kabi and FMC - Principal Manufacturing Locations, December 2012 31 Agreements Summary 33 Mergers and Acquisitions Summary 35 Fresenius - Key Corporate Events 41
List of Charts Fresenius SE - Annual Sales and Operating Income, 2008-2012 6 Fresenius SE - Annual Sales by Geographic Area, 2008-2012 7 FMC - Annual Sales by Product, 2008-2012 8 FMC - Annual Sales by Geographic Area, 2008-2012 9 Fresenius Employees by Business Division, 2012 14 Dialysis Products Worldwide Market Shares, 2012 15 Number of Patients Treated by Top 5 Dialysis Providers Worldwide, 2012 16 Fresenius Kabi - Annual Sales by Product Area, 2008-2012 25 Fresenius Group - 2012 RandD Expenditure by Business Segment 26